Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 41-50

  Sailler, Laurent ^a,b   Puissant, Bénédicte ^c   Méliani, Pascal ^b   Castex, Jean Olivier ^b   Saivin, Sylvie ^b   Adoue, D ^b   Fournie, B ^b   Arlet, Philippe ^b   Montastruc, Jean Louis ^a   Lapeyre Mestre, Maryse ^a   Pourrat, Jacques ^c   Blancher, Antoine ^c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU PURPAN   (France)

^c CHU RANGUEIL   (France)

Author keywords

Desethylhydroxychloroquine; Hydroxychloroquine; Lymphocytes; Smoking; Systemic lupus erythematosus

Indexed keywords

BASILIXIMAB; CD19 ANTIBODY; CD3 ANTIBODY; CD38 ANTIBODY; CD4 ANTIBODY; CD45RA ANTIBODY; CD45RO ANTIGEN; CD8 ANTIBODY; CD86 ANTIBODY; CORTICOSTEROID; DEETHYLHYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; BLOOD; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34948830989     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.005     Document Type: Conference Paper

References (15)

1. FESSLER, B.J. et al. 2005. Systemic lupus erythematosus in three ethnic groups. XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 52: 1473-1480.
2. THE CANADIAN HYDROXYCHLOROQUINE STUDY GROUP. 1991. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N. Engl. J. Med. 324: 150-154.
3. COSTEDOAT-CHALUMEAU, N. et al. 2006. Low blood hydroxychloroquine concentrations are a marker and a predictor of exacerbations in treated patients with systemic lupus erythematosus. Arthritis Rheum. 54: 3284-3290.
4. MUNSTER, T. et al. 2002. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum. 46: 1460-1469.
5. ILLEI, G.G. et al. 2004. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum. 50: 2048-2065.
6. GORDON, C. et al. 1996. Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br. J. Rheumatol. 35: 226-230
7. TETT, S.E. 2000. Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis-a prospective, dose ranging study. J. Rheumatol. 27: 1656-1660.
8. WOZNIACKA, A. et al. 2002. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. Lupus 11: 71-81.
9. MEANS, T.K. et al. 2005. Human lupus auto-antibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
10. RÖNNBLOM, L. et al. 2001. A pivotal role for the natural interferon α-producing cells (plamacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194: 59-63.
11. LOPEZ, P. et al. 2006. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. Arthritis Res. Ther. 8: R42.
12. + lymphocytes in physically active adults. Eur. J. Immunol. 23: 2704-2706.
13. GHAUSSY, N.O. et al. 2003. Cigarette smoking and disease activity in systemic lupus erythematosus. J. Rheumatol. 30: 1215-1221.
14. JEWELL, M.L. & D.P. MCCAULIFFE. 2000. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J. Am. Acad. Dermatol. 42: 983-987.
15. POLET, H. 1985. The effects of lysosomotropic amines on protein degradation, migration of non-histone proteins to the nucleus, and cathepsin D in lymphocytes. J. Cell. Physiol. 122:415-423.